comScore
Active Stocks
Fri Sep 29 2023 15:59:14
  1. Tata Steel share price
  2. 129 1.78%
  1. NTPC share price
  2. 245.65 3.3%
  1. Power Grid Corporation Of India share price
  2. 199.85 -0.45%
  1. State Bank Of India share price
  2. 598.7 1.48%
  1. Wipro share price
  2. 406.25 0.11%
Business News/ Markets / Stock Markets/  Jubilant Pharmova Q4 results: Consolidated net loss widens sequentially to 98 crore; to pay 5 per share dividend
Back

Jubilant Pharmova Q4 results: Consolidated net loss widens sequentially to ₹98 crore; to pay ₹5 per share dividend

Jubilant Pharmova's Q4 earnings were a mixed bag with bottom-line impacted due to higher expenses and exceptional items losses. Revenue recorded growth. The company's Q4 net loss widened to ₹98 crore on a sequential basis.

Despite net loss in FY23, in a meeting held on Monday, Jubilant's board of directors declared a dividend of  ₹5 per share for the fiscal FY23.Premium
Despite net loss in FY23, in a meeting held on Monday, Jubilant's board of directors declared a dividend of 5 per share for the fiscal FY23.

Jubilant Pharmova's net loss widened sequentially to 97.84 crore in the quarter ending March 31, 2023, period. In the preceding quarter, the company posted a loss of 15.67 crore. However, Jubilant posted a loss against a profit of 59.55 crore that was recorded in Q4FY22.

Profitability was impacted as total expenses in Q4FY23 shoot up drastically. In the quarter, total expenses stood at 1,785.57 crore versus 1,420.24 crore in Q4FY22 and 1,551.69 crore in Q3 of FY23.

Also, the company posted an exception items loss of 86.41 crore in the March 2023 quarter.

EBITDA also came in at 202.1 crore in the quarter under review, declining by 13.7% from 234.2 crore in Q4 of FY22. Similarly, EBITDA margins dipped to 12.2% in Q4 FY23, as against 15.5% in the same quarter last year.

Read here: Natco Pharma posts 345% sequential growth in Q4 PAT to 276 crore, revenue up 82%

However, the company recorded growth in terms of revenue from operations to 1,678 crore in Q4FY23, as against 1,552.51 crore in Q3FY23 and 1,527.53 crore in Q4FY22.

For the full year FY23, the revenue was at 6,281.73 crore compared to 6,130.16 crore in FY22. Meanwhile, the company saw a loss of 648.88 crore in FY23 as against a profit of 413.02 crore in FY22.

Read here: GMR Infra share price nosedived by 11% as net loss widens in Q4

Despite net loss in FY23, in a meeting held on Monday, Jubilant's board of directors declared a dividend of 5 per share having a face value of Re 1 each for the fiscal FY23.

The dividend, if approved by the shareholders at the ensuing Annual General Meeting of the company, then will be paid/dispatched within 30 days from the date of AGM.

On BSE, Jubilant Pharmova's share price closed at 357.75 apiece down by 1.4%. The stock was near its day's low of 355.65 apiece.

"Exciting news! Mint is now on WhatsApp Channels 🚀 Subscribe today by clicking the link and stay updated with the latest financial insights!" Click here!

Catch all the Business News, Market News, Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.
More Less
Updated: 29 May 2023, 04:36 PM IST
Next Story
Recommended For You
GENIE RECOMMENDS

Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!

Let’s get started
Switch to the Mint app for fast and personalized news - Get App